Price T Rowe Associates Inc. MD Buys 3,239,203 Shares of Xylem Inc. $XYL

Price T Rowe Associates Inc. MD raised its stake in shares of Xylem Inc. (NYSE:XYL) by 689.5% during the 1st quarter, Holdings Channel.com reports. The fund owned 3,708,963 shares of the industrial products company’s stock after acquiring an additional 3,239,203 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Xylem were worth $443,074,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. Capital Fund Management S.A. purchased a new stake in shares of Xylem during the 1st quarter valued at $4,445,000. Groupama Asset Managment grew its holdings in Xylem by 5.6% during the 1st quarter. Groupama Asset Managment now owns 17,635 shares of the industrial products company’s stock valued at $2,106,000 after buying an additional 943 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S grew its holdings in Xylem by 14.2% during the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 160,509 shares of the industrial products company’s stock valued at $19,174,000 after buying an additional 20,006 shares in the last quarter. Hsbc Holdings PLC grew its holdings in Xylem by 10.2% during the 1st quarter. Hsbc Holdings PLC now owns 1,490,931 shares of the industrial products company’s stock valued at $177,969,000 after buying an additional 137,972 shares in the last quarter. Finally, Texas Capital Bank Wealth Management Services Inc purchased a new position in Xylem during the 1st quarter valued at about $236,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Stock Performance

NYSE:XYL opened at $143.6210 on Friday. The firm has a market cap of $34.96 billion, a PE ratio of 37.30, a price-to-earnings-growth ratio of 2.43 and a beta of 1.11. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $145.33. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.90. The business has a 50 day moving average price of $134.27 and a 200-day moving average price of $126.45.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The business had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.20 billion. During the same period in the prior year, the business earned $1.09 EPS. The company’s revenue for the quarter was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Equities research analysts predict that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, August 28th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Thursday, August 28th. Xylem’s dividend payout ratio (DPR) is presently 41.56%.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on XYL shares. Wall Street Zen raised Xylem from a “hold” rating to a “buy” rating in a report on Saturday, August 9th. Robert W. Baird cut their price objective on Xylem from $149.00 to $146.00 and set an “outperform” rating for the company in a report on Wednesday, April 30th. UBS Group boosted their price objective on Xylem from $164.00 to $168.00 and gave the stock a “buy” rating in a report on Tuesday, August 5th. Royal Bank Of Canada boosted their price objective on Xylem from $143.00 to $147.00 and gave the stock an “outperform” rating in a report on Wednesday, April 30th. Finally, Stifel Nicolaus boosted their price objective on Xylem from $162.00 to $175.00 and gave the stock a “buy” rating in a report on Friday, August 1st. Six equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Xylem presently has a consensus rating of “Moderate Buy” and a consensus price target of $151.57.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.